MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas.

作者: A. Lasocki , A. Tsui , M. A. Tacey , K. J. Drummond , K. M. Field

DOI: 10.3174/AJNR.A4077

关键词:

摘要: BACKGROUND AND PURPOSE: Histologic grading of intracranial astrocytomas is affected by sampling error and substantial inter- intraobserver variability. We proposed that incorporating MR imaging into will predict patient survival more accurately than histopathology alone. MATERIALS METHODS: Patients with a new diagnosis World Health Organization grades II–IV astrocytoma or mixed oligoastrocytoma diagnosed between September 2007 December 2010 were identified. Two hundred forty-five patients met the inclusion criteria. Preoperative MRIs independently reviewed 2 readers blinded to histologic grade, an grade was given. The histopathologic compared survival. RESULTS: II III on histology but evidence necrosis (consistent IV tumor) had significantly worse same no ( P = .002 for .029 III). Their not different from in tumors .164 .385, respectively); this outcome suggests all most are likely have truly been tumors. less frequent oligoastrocytomas, preventing adequate subgroup analysis. CONCLUSIONS: can improve identifying suspected being undergraded histology, high interobserver agreement. This finding has potential optimize management, example, encouraging aggressive treatment earlier patient9s course.

参考文章(32)
H. R. Arvinda, C. Kesavadas, P. S. Sarma, B. Thomas, V. V. Radhakrishnan, A. K. Gupta, T. R. Kapilamoorthy, S. Nair, Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging Journal of Neuro-oncology. ,vol. 94, pp. 87- 96 ,(2009) , 10.1007/S11060-009-9807-6
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
Parakrama T. Chandrasoma, Maurice M. Smith, Michael L. J. Apuzzo, Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery. ,vol. 24, pp. 160- 165 ,(1989) , 10.1227/00006123-198902000-00002
Paul D. Brown, Low-grade gliomas: The debate continues Current Oncology Reports. ,vol. 8, pp. 71- 77 ,(2006) , 10.1007/S11912-006-0012-X
Richard A. Prayson, Dimitri P. Agamanolis, Mark L. Cohen, Melinda L. Estes, B.K. Kleinschmidt-DeMasters, Fadi Abdul-Karim, Stephen P. McClure, Bruce A. Sebek, Robin Vinay, Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. Journal of the Neurological Sciences. ,vol. 175, pp. 33- 39 ,(2000) , 10.1016/S0022-510X(00)00274-4
Kathryn M Field, Katharine J Drummond, Merve Yilmaz, Mark Tacey, Daniel Compston, Peter Gibbs, Mark A Rosenthal, None, Clinical trial participation and outcome for patients with glioblastoma: Multivariate analysis from a comprehensive dataset Journal of Clinical Neuroscience. ,vol. 20, pp. 783- 789 ,(2013) , 10.1016/J.JOCN.2012.09.013
Singh Avninder, Mehar Chand Sharma, Prabal Deb, Veer Singh Mehta, Asish Kumar Karak, Ashok Kumar Mahapatra, Chitra Sarkar, Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations – a study of 32 cases Journal of Neuro-oncology. ,vol. 78, pp. 123- 127 ,(2006) , 10.1007/S11060-005-9077-X
Edmond A. Knopp, Soonmee Cha, Glyn Johnson, Avi Mazumdar, John G. Golfinos, David Zagzag, Douglas C. Miller, Patrick J. Kelly, Irvin I. Kricheff, Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology. ,vol. 211, pp. 791- 798 ,(1999) , 10.1148/RADIOLOGY.211.3.R99JN46791